Rhythm Pharmaceuticals (RYTM) P/B ratio

P/B ratio today
28.1×

Rhythm Pharmaceuticals (RYTM) trades at 28.1× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 25.8×. That is 24.1% higher than the 20.8× of fiscal 2024. Figures as of 18 Nov 2026, 04:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
28.1×
P/B ratio, fiscal 2025
25.8×
Change on fiscal 2024
+24.1%
Highest on record
25.8×fiscal 2025
Lowest on record
1.7×fiscal 2021
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Rhythm Pharmaceuticals P/B ratio, in more detail

Today's figure is 8.9% above the fiscal 2025 year-end.

Across the 7 fiscal year-ends on record (2019–2025), the highest was 25.8× in fiscal 2025 and the lowest 1.7× in fiscal 2021. Today's P/B ratio is above every one of the 7 fiscal year-ends on record; their median is 7.9×.

History · 7 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Rhythm Pharmaceuticals P/B ratio, year by year

Rhythm Pharmaceuticals (RYTM) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today28.1×—$116.61—
202525.8× 24.1% up$107.04$4.16
202420.8× 32.9% up$55.98$2.70
202315.6× 171.9% up$45.97$2.94
20225.7× 229.7% up$29.12$5.07
20211.7× 77.9% down$9.98$5.73
20207.9× 164.7% up$29.73$3.77
20193.0×—$22.96$7.72
2018——$26.88—
2017——$29.06—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of Rhythm Pharmaceuticals and comparable companies
CompanyP/B ratio
Rhythm Pharmaceuticals RYTM29.9×
Alkermes ALKS4.2×
PACS Group PACS8.1×
Kiniksa Pharmaceuticals International KNSA13.2×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on RYTM

Rhythm Pharmaceuticals, figure by figure

Rhythm Pharmaceuticals (RYTM) overview: price, valuation and scorecardAll health care companies by market value

Rhythm Pharmaceuticals P/B ratio: questions and answers

What is Rhythm Pharmaceuticals's P/B ratio?

Rhythm Pharmaceuticals (RYTM) trades at 28.1× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 25.8×. That is 24.1% higher than the 20.8× of fiscal 2024.

Is Rhythm Pharmaceuticals's P/B ratio high or low compared with its own history?

Today's P/B ratio is above every one of the 7 fiscal year-ends on record; their median is 7.9×.

What are the highest and lowest P/B ratio figures on record for Rhythm Pharmaceuticals?

Across the 7 fiscal year-ends on record (2019–2025), the highest was 25.8× in fiscal 2025 and the lowest 1.7× in fiscal 2021.

How is Rhythm Pharmaceuticals's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Rhythm Pharmaceuticals (RYTM) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/RYTM/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.